IBM Aspera Faspex 4.4.1 XSS: Arbitrary JS in Web UI (Pre-4.4.2)
CVE-2023-22868 Published on February 17, 2023

IBM Aspera Faspex cross-site scripting
IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.

Vendor Advisory NVD

Vulnerability Analysis

CVE-2023-22868 is exploitable with network access, requires user interaction and a small amount of user privileges. This vulnerability is considered to have a low attack complexity. The potential impact of an exploit of this vulnerability is considered to have a small impact on confidentiality and integrity, and no impact on availability.

Attack Vector:
NETWORK
Attack Complexity:
LOW
Privileges Required:
LOW
User Interaction:
REQUIRED
Scope:
CHANGED
Confidentiality Impact:
LOW
Integrity Impact:
LOW
Availability Impact:
NONE

Weakness Type

What is a XSS Vulnerability?

The software does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.

CVE-2023-22868 has been classified to as a XSS vulnerability or weakness.


Products Associated with CVE-2023-22868

Want to know whenever a new CVE is published for IBM Aspera Faspex? stack.watch will email you.

IBM Aspera Faspex
 

Affected Versions

IBM Aspera Faspex Version 4.4.1 is affected by CVE-2023-22868

Exploit Probability

EPSS
0.20%
Percentile
41.89%

EPSS (Exploit Prediction Scoring System) scores estimate the probability that a vulnerability will be exploited in the wild within the next 30 days. The percentile shows you how this score compares to all other vulnerabilities.